Decades of underfunding mean that we still lack the tests and treatments to tackle this brutal disease. Hope alone can’t fix this. People with pancreatic cancer need action now.
That’s why our research strategy is vitally important. It aims to transform the future for people with pancreatic cancer. From cutting-edge tests to cancer-killing therapies, our scientists are striving for earlier detection and better treatment.
We’re also investing in the brightest minds, to grow the research community and accelerate the life-saving breakthroughs that we so urgently need.
Late diagnosis is one of the biggest issues in pancreatic cancer but we’re investing in ground-breaking research to change this.
As well as investing in research to save lives, we’re also working to transform people’s experience of pancreatic cancer, funding new approaches and encouraging innovative thinking.
Our strategy lays out how we will work with world leading researchers and with people affected by pancreatic cancer, to fund research that will transform and save lives.
Researchers will find the breakthroughs needed in pancreatic cancer, so we must do everything we can to build and support the community.
Find out more about opportunities for funding and support for the pancreatic cancer research community. Together we are the research community taking pancreatic cancer on.
30 March 2026
An update on our work to address the PERT shortages, including the progress we've made so far, the current supply situation, and what we still need to...
30 March 2026
Announcing that the world’s first breath test for pancreatic cancer was entering a national clinical trial was one of the most significant milestones ...
16 March 2026
We are absolutely delighted that on Thursday 5th March, the Rare Cancers Bill passed its final stage in Parliament, receiving Royal Assent and becomin...
30 March 2026
An update on our work to address the PERT shortages, including the progress we've made so far, the current supply situation, and what we still need to...
30 March 2026
Announcing that the world’s first breath test for pancreatic cancer was entering a national clinical trial was one of the most significant milestones ...
16 March 2026
We are absolutely delighted that on Thursday 5th March, the Rare Cancers Bill passed its final stage in Parliament, receiving Royal Assent and becomin...
